226 related articles for article (PubMed ID: 19240082)
1. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.
Blomster HA; Hietakangas V; Wu J; Kouvonen P; Hautaniemi S; Sistonen L
Mol Cell Proteomics; 2009 Jun; 8(6):1382-90. PubMed ID: 19240082
[TBL] [Abstract][Full Text] [Related]
2. In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.
Blomster HA; Imanishi SY; Siimes J; Kastu J; Morrice NA; Eriksson JE; Sistonen L
J Biol Chem; 2010 Jun; 285(25):19324-9. PubMed ID: 20388717
[TBL] [Abstract][Full Text] [Related]
3. PDSM, a motif for phosphorylation-dependent SUMO modification.
Hietakangas V; Anckar J; Blomster HA; Fujimoto M; Palvimo JJ; Nakai A; Sistonen L
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):45-50. PubMed ID: 16371476
[TBL] [Abstract][Full Text] [Related]
4. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
5. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
6. A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9.
Mohideen F; Capili AD; Bilimoria PM; Yamada T; Bonni A; Lima CD
Nat Struct Mol Biol; 2009 Sep; 16(9):945-52. PubMed ID: 19684601
[TBL] [Abstract][Full Text] [Related]
7. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
8. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
Filosa G; Barabino SM; Bachi A
Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
[TBL] [Abstract][Full Text] [Related]
9. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
10. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
12. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
[TBL] [Abstract][Full Text] [Related]
14. An extended consensus motif enhances the specificity of substrate modification by SUMO.
Yang SH; Galanis A; Witty J; Sharrocks AD
EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
[TBL] [Abstract][Full Text] [Related]
15. SUMO assay with peptide arrays on solid support: insights into SUMO target sites.
Schwamborn K; Knipscheer P; van Dijk E; van Dijk WJ; Sixma TK; Meloen RH; Langedijk JP
J Biochem; 2008 Jul; 144(1):39-49. PubMed ID: 18344540
[TBL] [Abstract][Full Text] [Related]
16. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
17. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
18. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion.
Osula O; Swatkoski S; Cotter RJ
J Mass Spectrom; 2012 May; 47(5):644-54. PubMed ID: 22576878
[TBL] [Abstract][Full Text] [Related]
19. System-wide identification of wild-type SUMO-2 conjugation sites.
Hendriks IA; D'Souza RC; Chang JG; Mann M; Vertegaal AC
Nat Commun; 2015 Jun; 6():7289. PubMed ID: 26073453
[TBL] [Abstract][Full Text] [Related]
20. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
Sampson DA; Wang M; Matunis MJ
J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]